Premium
Tamsulosin versus transurethral resection of the prostate: Effect on nocturia as a result of benign prostatic hyperplasia
Author(s) -
Simaioforidis Vasileios,
Papatsoris Athanasios G,
Chrisofos Michael,
Chrisafis Manolis,
Koritsiadis Sotirios,
Deliveliotis Charalambos
Publication year - 2011
Publication title -
international journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.172
H-Index - 67
eISSN - 1442-2042
pISSN - 0919-8172
DOI - 10.1111/j.1442-2042.2010.02704.x
Subject(s) - nocturia , medicine , tamsulosin , urology , international prostate symptom score , lower urinary tract symptoms , transurethral resection of the prostate , prostate , gynecology , hyperplasia , urinary system , cancer
Our objective was to compare the effect of tamsulosin versus transurethral resection of the prostate (TURP) for the management of nocturia in previously untreated men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) and no other predisposing factors for nocturia. The study group included 66 patients (mean age 68.9 years, range 52–81) randomized to receive either tamsulosin 0.4 mg per os daily ( n = 33) or TURP ( n = 33). Nocturia was assessed at baseline, after 3 months and after 1 year, by the number of nocturnal awakenings and hours of undisturbed sleep (HUS) obtained from a 72‐h Frequency Volume Chart (FVC). Furthermore, the International Prostate Symptom Score (IPSS), the International Consultation on Incontinence Questionnaire Nocturia (ICIQ‐N) and the International Consultation on Incontinence Questionnaire Nocturia Quality of Life (ICIQ‐NQoL) were recorded. At baseline, there were no statistically significant differences between the two groups. ICIQNQoL and ICIQ‐N scores correlated with the number of awakenings and HUS, respectively. Both tamsulosin and TURP improved all examined parameters during the follow up. TURP was associated with a statistically significant improvement in the number of nocturnal awakenings and in the IPSS, ICIQ‐N and ICIQ‐NQol scores in comparison with tamsulosin. HUS increased in both groups, but without any statistically significant difference. In conclusion, TURP is superior in comparison with tamsulosin for the management of BPH‐related nocturia.